1472037835
Obesity: A Disease

Advertise on podcast: Obesity: A Disease

Rating
★★★★★
4.6
from
63 reviews
This podcast has
127 episodes
Language
English
Explicit
No
Date created
2019/07/08
Latest episode
2026/10/19
Average duration
29 min.
Release period
27 days

Description

Obesity: A Disease is the official Obesity Medicine Association (OMA) FREE podcast exploring the many facets of the disease of obesity. Episodes provide valuable insights into this growing problem and better equip clinicians to understand and engage in treating this disease.

Unlock Obesity: A Disease podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Obesity: A Disease podcast


Episode 133: Clinical Conversations: Understanding CKM Syndrome in Obesity Care
2026/10/19
In this episode of Obesity: A Disease, presented by the Obesity Medicine Association (OMA) in collaboration with the American Heart Association (AHA), Dr. Chiadi Ndumele joins the discussion to explore Cardiovascular-Kidney-Metabolic (CKM) Syndrome and its implications for obesity care. Learn how the CKM framework and staging system can help clinicians assess cardiovascular risk, identify opportunities for early intervention, and develop individualized treatment strategies. The conversation also examines the impact of weight loss on cardiometabolic outcomes and the role of lifestyle interventions, anti-obesity medications, and bariatric surgery in improving long-term health. Episode Guest: Chiadi Ndumele, MD, PhD, MHS Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP Chapters (00:00:01) - Introduction and Case Presentation(00:01:05) - Guest Introduction: Dr. Ndumele's Background(00:02:29) - What is Cardiovascular Kidney Metabolic (CKM) Syndrome?(00:03:50) - Shifting Drivers of Cardiometabolic Disease(00:04:55) - Underlying Pathophysiology: Inflammation and Insulin Resistance(00:05:48) - How CKM Guidelines Address Interconnected Risk(00:07:21) - CKM Staging System Explained(00:11:14) - Risk Progression, Synergy, and Mortality(00:12:12) - Metrics for Assessing CKM Risk(00:14:11) - Fatty Liver Disease and the Fib-4 Index(00:14:57) - Using the PREVENT Score and Add-On Variables(00:15:57) - Social Deprivation and Health Equity in CKM(00:17:04) - Obesity as a Centerpiece of Cardiometabolic Risk(00:18:11) - How Much Weight Loss Matters for Cardiometabolic Health(00:20:28) - GLP-1 Agents and Weight-Independent Cardiovascular Benefits(00:21:42) - Key Takeaways for Non-Cardiologist Clinicians(00:24:38) - Closing Thoughts and Sign-Off
Episode 132: Clinical Conversations: Using EPSDT to Improve Access to Obesity Pharmacotherapy in Youth
2026/09/18
In this episode of Obesity: A Disease, Dr. Suzanne Cuda, Executive Editor of the Obesity Medicine Association’s Obesity Pillars online journal, interviews Dr. Alaina Vidmar and Dr. Valerie O’Hara about their co-authored article, Using EPSDT to Improve Access to Obesity Pharmacotherapy, published in Obesity Pillars. Together they discuss using the federally mandated Medicated provision, Early and Periodic Screening, Diagnostic and Treatment (EPSDT) to access coverage for obesity treatment of youth in Medicaid programs. Episode Guests: Alaina Vidmar, MD Valerie O’Hara, DO, FAAP, FOMA, DABOM Episode Host: Suzanne Cuda, MD, FOMA, FAAP Related Resources: https://www.sciencedirect.com/science/article/pii/S2667368126000422  Chapters (00:00:01) - Introduction and guest introductions(00:02:51) - What is EPSDT?(00:03:38) - Motivation for the review and personal experiences(00:06:58) - Navigating state vs federal Medicaid rules(00:10:17) - Why obesity deserves EPSDT-based treatment(00:13:05) - Fighting bias and stigma through EPSDT(00:13:51) - Finding resources and champions in your state(00:17:44) - Practical steps: denials, appeals, and letters of necessity(00:19:35) - Variability and challenges across insurers(00:22:29) - Transition to adulthood and coverage gaps(00:24:26) - Using comorbidities and creative coverage strategies(00:28:10) - Advocacy: crafting effective appeal letters(00:31:39) - Case study: dose escalation denial example(00:34:32) - Systemic barriers and future data collection(00:37:35) - Comparing EPSDT to Bridge and Balance programs(00:39:36) - Closing thoughts and thanks
Episode 131: Clinical Conversations: OMA Practice Management Algorithm
2026/08/27
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings is joined by Dr. Courtney Younglove to explore OMA’s new Practice Management Algorithm, a practical resource designed to help clinicians navigate the business and operational complexities of obesity medicine practice. The conversation examines the gaps the Practice Management Algorithm was developed to address, how its eight practice management domains can support clinicians across a variety of practice models and career stages, and how the resource can be used to tackle real-world operational and financial challenges. Episode Guest: Courtney Younglove, MD, MSCP, DABOM, FOMA, FACOG, DABOM, Primary Author of the OMA's Practice Management Algorithm Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP Chapters (00:00:01) - Obesity a Disease: Practice Management Algorithm(00:01:35) - How to start and grow a medical practice with obesity medicine(00:03:18) - The Practice Management Algorithm for Obesity Medicine(00:06:29) - The Pediatric Outcomes of the ACA(00:07:44) - The role of pediatrics in the health system(00:08:26) - Practice Management Algorithm(00:12:09) - Post-Doctor: The Challenges of Starting a Business(00:13:50) - Obstructive Medicine Practice Management Algorithm(00:22:00) - Obesity a Disease: The Conference Document
Episode 130: Clinical Conversations: Access, Coverage & Health Equity in 2026
2026/07/27
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings is joined by Dr. Tracy Norfleet and Dr. Alicia Shellly to discuss how the rapidly evolving landscape of access, insurance coverage, and health equity is shaping obesity care in 2026. Together, they explore the impact of Medicare, Medicaid, and commercial insurance policies on health equity and discuss strategies to ensure advances in obesity care benefit all patients. Episode Guests: Tracy Norfleet, MD, DABOM Alicia Shelly MD, DABOM Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP Chapters (00:00:01) - Obesity a Disease: Medical Coverage(00:01:35) - Two physicians discuss obesity and the treatment of obesity patients(00:02:33) - Obesity medication coverage in 2026(00:05:26) - Obesity Health Care Disparities(00:08:45) - How to address weight bias in healthcare(00:13:05) - Obesity Medications Coverage(00:21:51) - Obesity and medical documentation(00:25:14) - Obesity Medicine: Advocacy for Patients
Episode 129: Clinical Conversations: Nutrition for Weight Maintenance After Medication or Surgery
2026/06/22
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings is joined by Co-Clinical Education Director, Dr. Kirsten Frederiksen, together, they unpack the physiology behind rapid weight regain after stopping obesity medications, explore the most effective dietary and lifestyle strategies for long-term weight maintenance, and discuss how clinicians can reframe the conversation with patients from the very start of treatment. Episode Guest: Kirsten Frederiksen, MD, MSc, FACP, FOMA, DABOM Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP Chapters (00:00:01) - Nutrition for Weight Maintenance after medication(00:01:13) - Weight maintenance is a chronic disease(00:10:12) - Weight regain after lapidomycin therapy(00:14:25) - Physical Activity and Weight Maintenance(00:19:07) - Weight Maintenance with obese patients(00:23:49) - Weight maintenance, 3 nutritional principles(00:26:22) - Obesity a Disease
Episode 128: Clinical Conversations: Protein, Muscle, and Sarcopenic Obesity
2026/05/25
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings sits down with Dr. Renee Rogers for an insightful discussion on the critical role of muscle preservation during weight loss therapy. Together, they explore the latest evidence surrounding lean mass retention and share practical, evidence-based strategies clinicians can apply to help patients maintain muscle, enhance metabolic health, and achieve more sustainable treatment outcomes. Episode Guest: Renee Rogers, PhD, FACSM, FTOS, and Chair of ACSM’s Strategic Health Initiative (SHI) for Behavior and Chair of ACSM’s International Health & Fitness Summit Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
Episode 127: Clinical Conversations: Nutrition in the GLP-1 Era
2026/04/06
In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings engages in a discussion with Dr. Sue Benson Davies, exploring evidence-informed strategies to prevent undernutrition during weight loss in the evolving landscape of GLP-1–based care. Together, they examine optimal protein targets, approaches to managing food aversion and diminished appetite, and practical nutrition counseling techniques to support safe and sustainable patient outcomes. Episode Guest: Sue Benson-Davies, PhD, DCN, MPH, RDN, LN, FAND Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
Episode 126: Industry Insights: Metabolic Resting Rate
2026/04/03
In this Industry Insights episode of Obesity: A Disease, host Dr. Christopher Weber welcomes Dr. Cameron Garber and Dr. Marc Humbert, metabolic testing specialists with Korr Medical Technologies and hosts of the Metabolic Mastery podcast. Dr. Garber and Dr. Humbert join Dr. Christopher Weber for a focused discussion on resting metabolic rate, exploring its role as a vital sign, its application in nutritional planning, and what the future holds for metabolic testing. This episode is sponsored by Korr Medical Technologies. To learn more about Korr’s metabolic test equipment, visit //KORR.com/OMA or visit them at booth #113 at the 2026 Obesity Medicine Conference in San Diego, CA. Episode Guests: Cameron Garber, DPT Marc Humbert, DPT Episode Host: Christopher Weber, MD, FAAP, FACP, CSCS, DABOM, FOMA The opinions expressed in this podcast are those of the individual speakers and do not represent the views or positions of the Obesity Medicine Association (OMA). This content is intended for informational purposes only. Chapters (00:00:01) - Obesity a Disease(00:01:25) - Resting metabolic rate (RMR)(00:06:53) - MRK: Metabolism, Science(00:13:12) - Exercise and Weight Loss(00:20:49) - Resting metabolic rate(00:24:21) - Metabolic rate monitoring(00:29:57) - Cost of care, Medicare, private insurance(00:31:51) - Heart disease and weight loss(00:41:06) - Weight Loss on GLP1s(00:49:43) - The Future of Weight Loss and Management(00:53:59) - Weight Management: Obesity, a Disease
Episode 125: Industry Insights: Surmount OSA Trial
2026/03/31
In this Industry Insights episode of Obesity: A Disease, host Dr. Christopher Weber welcomes Dr. Kevin Trice, Executive Director in the Global Medical Affairs Division of Cardiometabolic Health at Eli Lilly. Dr. Trice will be speaking today on behalf of Lilly. This material is developed under the direction and sponsorship of Lilly Medical Affairs and is intended for US healthcare professional only. Dr. Trice is an employee of Eli Lilly.  Dr. Kevin Trice joins Dr. Christopher Weber for a focused discussion on the key findings from the SURMOUNT-OSA trial and their implications for clinical practice. Together, they explore how this landmark study informs the evolving management of obesity and obstructive sleep apnea.  This episode is sponsored by Lilly. Episode Guest: Kevin Trice, MD, MBA Episode Host: Christopher Weber, MD, FAAP, FACP, CSCS, DABOM, FOMA Note From the Sponsor *When discussing tirzepatide for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, it’s important to emphasize that its safety profile mirrors what we’ve seen in obesity and diabetes indications. The most frequent adverse events are gastrointestinal—nausea, diarrhea, vomiting, and constipation—typically emerging during dose escalation and generally mild to moderate in severity. While these symptoms often resolve over time, clinicians should monitor for persistence or intolerance, as discontinuation, though uncommon, can occur. Serious but rare risks include pancreatitis and gallbladder disease; patients presenting with severe abdominal pain warrant immediate evaluation. Tirzepatide carries a boxed warning for thyroid C-cell tumors based on rodent data, with uncertain relevance to humans. It is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2. Physicians should counsel patients on recognizing symptoms such as neck swelling or persistent hoarseness. Additional precautions include vigilance for severe gastrointestinal symptoms, hypersensitivity reactions, and pancreatitis. Use during pregnancy is not recommended, and effective contraception should be discussed. Finally, consider potential drug interactions and reinforce lifestyle interventions to optimize outcomes alongside pharmacotherapy.*
Episode 124: The Impact of Ultra-Processed Foods on Pediatric Health
2025/11/20
In this episode of Obesity: A Disease, Dr. Suzanne Cuda, Executive Editor of the Obesity Medicine Association’s Obesity Pillars online journal, interviews Dr. Sarah Ro and Dr. Sushma Chamarthi about their co-authored article, The Impact of Ultra-Processed Foods on Pediatric Health, published in Obesity Pillars. Together they discuss the impact and increasing prevalence of ultra-processed foods into pediatric diets. Episode Guests: Sarah Ro, MD, DABOM Sushma Chamarthi, MD, FAAP, DABOM Episode Host: Suzanne Cuda, MD, FOMA, FAAP Related Resources: https://www.sciencedirect.com/science/article/pii/S2667368125000476
Episode 123: Obesity and Orthopedic Surgical Care - Challenges and Advances
2025/11/06
In this eighth and final episode of the series, Dr. Allison Rhodes concludes the discussion on obesity and orthopedic health with Dr. Cherise Dyal, focusing on the unique post-operative risks and recovery challenges following lower extremity surgery in patients with obesity. Together, they examine complications in lower extremity procedures that can be influenced by obesity, as well as the factors contributing to extended recovery timelines and complex rehabilitation needs. The episode also explores strategies to enhance surgical and functional outcomes.  Dr. Rhodes and Dr. Dyal underscore the importance of a team-based, patient-centered approach that supports safe recovery, sustained mobility, and long-term musculoskeletal health. This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy.  *This activity is supported by an independent educational grant from Novo Nordisk Inc. Episode Guest: Dr. Cherise Dyal, MD, DABOM is a Board Certified Orthopedic Surgeon. She is a Fellow of the American Academy of Orthopedic Surgery and is also Board Certified in Obesity Medicine. Episode Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center
Episode 122: Obesity and Orthopedic Surgery with Dr. Cherise Dyal
2025/11/06
In this seventh episode of our eight part series, Dr. Allison Rhodes welcomes Dr. Cherise Dyal, MD, DABOM. Dr. Dyal is a Board Certified Orthopedic Surgeon and together, they examine the complex relationship between obesity and lower extremity disorders. The discussion explores the heightened prevalence of foot, ankle, hip, and knee conditions among individuals with obesity and how these issues contribute to pain, reduced mobility, and diminished quality of life. Dr. Dyal provides a clinical perspective on the management of common lower extremity conditions in patients with obesity, as well as strategies to optimize patient outcomes. The episode highlights evidence-based approaches that support mobility, mitigate progression, and enhance overall musculoskeletal health. This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy.  *This activity is supported by an independent educational grant from Novo Nordisk Inc. Episode Guest: Dr. Cherise Dyal, MD, DABOM is a Board Certified Orthopedic Surgeon. She is a Fellow of the American Academy of Orthopedic Surgery and is also Board Certified in Obesity Medicine. Episode Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center
Episode 121: Endocrine Challenges and Advances in Patients with Obesity
2025/10/23
In this sixth episode of our eight part series, Dr. Allison Rhodes welcomes back Dr. Megha Poddar, MD, FRCPC, DABOM, to explore the unique challenges of managing endocrine disorders in patients with obesity. They discuss the complexities of medication dosing and efficacy, diagnostic limitations, and barriers to lifestyle change, along with the long-term management of diabetes, PCOS, and thyroid disease and their impact on metabolic and reproductive health. The conversation also highlights exciting advances in endocrine care, updates in fertility and PCOS management, and the integration of metabolic surgery into treatment plans. Together, Dr. Rhodes and Dr. Poddar emphasize the importance of a compassionate, patient-centered approach that addresses the interconnected nature of hormone and metabolic health to support better long-term outcomes. This podcast offers 0.5 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy.  *This activity is supported by an independent educational grant from Novo Nordisk Inc. Episode Guest: Megha Poddar, MD, FRCPC, DABOM is an endocrinologist and obesity medicine specialist, Medical Director of the Medical Weight Management Centre of Canada, and Assistant Clinical Professor at McMaster University Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center
Episode 120: Obesity and Endocrinology with Dr. Megha Poddar
2025/10/23
In this fifth episode of our eight part series, Dr. Allison Rhodes is joined by Dr. Megha Poddar, MD, FRCPC, DABOM, to explore how obesity intersects with hormone health. Together, they examine the complex relationship between obesity and endocrine function, highlighting how hormonal imbalances influence metabolic and reproductive health. Dr. Poddar discusses key conditions linked to obesity, including insulin resistance and Type 2 diabetes, MASLD/MASH, metabolic syndrome, thyroid disorders, and polycystic ovary syndrome (PCOS). The conversation also emphasizes the importance of early screening, lifestyle interventions, and collaboration between endocrinology and obesity medicine to improve patient outcomes. This podcast offers 0.5 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy.  *This activity is supported by an independent educational grant from Novo Nordisk Inc. Episode Guest: Megha Poddar, MD, FRCPC, DABOM is an endocrinologist and obesity medicine specialist, Medical Director of the Medical Weight Management Centre of Canada, and Assistant Clinical Professor at McMaster University Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center
Episode 119: Obesity and Gynecologic Care – Challenges and Advances
2025/10/16
Hosted by Dr. Allison Rhodes, this exciting new 8 part series explores how obesity intersects with a wide range of medical specialties. In each episode, we’ll dive into the challenges and opportunities for improving patient care when addressing obesity in different clinical contexts. In this fourth episode, Dr. Allison Rhodes is joined again by Dr. Kimberley Sampson-Paine to explore the unique challenges and advances in gynecological care for patients with obesity. Building on the foundation of Episode 3, they shift the focus to clinical management and treatment advances. This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy.  *This activity is supported by an independent educational grant from Novo Nordisk Inc. Episode Guest: Kimberley Sampson-Paine, MD, MSc, FACOG, DABOM, DACLM, MSCP, FOMA, Chair of Obstetrics and Gynecology at Southwestern Vermont Medical Center, Assistant Professor at the Geisel School of Medicine at Dartmouth, and Vice President of the New England Obesity Society Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

Podcast reviews

Read Obesity: A Disease podcast reviews


4.6 out of 5
63 reviews
★★★★★
Zeezee1985 2025/02/25
Informative podcast on the topic.
This excellent podcast offers an inspiring look into the expanding field of obesity medicine. Dr. Harold Bays is a fantastic host, and Dr. Yuval Pinto...
★★★★★
apmdsass 2024/04/10
Excellent podcast!
I have learned so Much from the podcast! Please don’t stop producing it!
★★★☆☆
radiem! 2023/04/24
Please fix editing issues
Great podcast when I can listen seamlessly. Two of the three episodes that I’ve tried to listen to have major editing issues where the audio starts ...
★★★★★
Redsg33 2023/03/29
Learning so much
I am a new member of the OMA and really enjoying this podcast. I am learning so much and I’m inspired to seek my ABOM certification.
★★★★★
BENNY2005 2019/11/07
Topics
Great precise topics. Love this podcast
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on Obesity: A Disease relevant audience podcasts


What do you want to promote?